Morphea, or localized scleroderma, can at times constitute a severely disabling and
aggressive disease with no single therapy proven to be curative or the standard of care …

UC Davis Page 1 UC Davis Dermatology Online Journal Title Generalized morphea
successfully treated with extracorporeal photochemotherapy (ECP). Permalink https://escholarship.org/uc/item/86f3g7zj …

BACKGROUND: Morphea (localized scleroderma) is a skin disorder with significant
morbidity. No consistent recommendations exist for therapy, impeding patient care …

Localized scleroderma (also known as morphea) is a chronic autoimmune disorder
characterized by depressed, fibrotic, and dyschromic cutaneous lesions. It has a significant …

Morphea is a group of cutaneous conditions, also termed localised scleroderma, that is
characterised by benign inflammation of the skin. We present a case of cutaneous …

A 17‐year‐old C aucasian woman presented for evaluation and treatment of a tender
expanding linear plaque on her left flank. Biopsy findings were consistent with morphea …

Morphea is a rare fibrosing disorder of the skin and underlying tissues. The underlying
pathogenesis of morphea is not completely understood at this time, but ultimately results in …

Morphea, also known as localized scleroderma, is characterized by idiopathic fibrosis of the
skin and adjacent structures. Patients with morphea classically present with skin lesions …

The term “morphea” includes a wide spectrum of clinical entities, varying from localized
plaques of only cosmetic importance to deep lesions resulting in considerable morbidity for …

Background: Extracorporeal photochemotherapy (EP) is a new immune-modulating therapy
which combines cytapheresis and extracorporeal irradiation of leukocytes by UVA. Recently …